Interaction of the glutathione S-transferase genes and cigarette smoking on risk of lower extremity arterial disease: the Atherosclerosis Risk in Communities (ARIC) study

被引:54
|
作者
Li, RL
Folsom, AR
Sharrett, AR
Couper, D
Bray, M
Tyroler, HA
机构
[1] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA
[2] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55454 USA
[3] NHLBI, DECA, NIH, Bethesda, MD 20892 USA
[4] Collaborat Studies Coordinating Ctr, Chapel Hill, NC 27514 USA
[5] Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77225 USA
关键词
GSTM1; GSTT1; gene-smoking interaction; lower extremity arterial disease;
D O I
10.1016/S0021-9150(00)00582-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glutathione S-transferases Ml or T1 (GSTM1/GSTT1) affect the body's ability either to detoxify or to activate chemicals in cigarette smoke. Cigarette smoking increases the risk of lower extremity arterial disease (LEAD). We conducted a cross-sectional study to evaluate a hypothesized interaction of the genetic polymorphisms of GSTM1 and T1 with cigarette smoking in the risk of LEAD in the ARIC study. A stratified-random sample, including 212 LEAD cases (ankle-brachial index < 0.9 in men or < 0.85 in women) and 1277 non-cases, was selected From the ARIC cohort of 12 041 middle-aged participants free of CHD, transient ischemic attack and stroke at baseline (1987-1989). Overall, the differences in the Frequencies of GSTM1-0 and GSTT1-0 (the homozygous deletion genotype) were not statistically significant between cases and non-cases (44 vs. 41% and 28 vs. 18%). However. smoking was more prevalent among LEAD cases than non-cases. The results suggest that the non-deletion genotype GSTM1-1 interacts with smoking to increase the risk of LEAD, but this interaction was not statistically significant. The functional genotype GSTT1-1 was significantly associated with increased risk of LEAD given smoking after adjustment for other risk factors. In individuals with GSTT1-1, the odds ratios (ORs) (95% confidence intervals) of LEAD were 3.6 (1.4, 9.0) for current smoking and 5.0 (1.9, 13.0) for 20 + pack-years. However, in those with GSTT1-0, the ORs were 0.8 (0.2, 2.8) for current smoking and 0.6 (0.1,2.1) for 20 + pack-years. The interaction was significant (P < 0.05) on the additive scale for current smoking and on both the additive and multiplicative scales for 20 + pack-years. Among non-smokers, GSTT1-1 was not associated with LEAD. The results suggest that the GSTT1-1 polymorphism may be a susceptibility factor modifying the risk of LEAD associated with cigarette smoking. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:729 / 738
页数:10
相关论文
共 50 条
  • [21] Polymorphic glutathione S-transferase genes in lung cancer risk
    Lima, Carmen S.
    Honma, Helen N.
    Lourenco, Gustavo J.
    Perroud-, Mauricio W., Jr.
    Barbeiro, Aristoteles S.
    Costa, Fernando F.
    Lima, Carmen S.
    Zambon, Lair
    ANNALS OF ONCOLOGY, 2006, 17 : 242 - 242
  • [22] The Association of Height With Incident Peripheral Arterial Disease in the Atherosclerosis Risk in Communities (ARIC) Study
    Menez, Steven P.
    Kwak, Lucia
    Ding, Ning
    Hicks, Caitlin
    Grams, Morgan
    Folsom, Aaron
    Heiss, Gerardo
    Selvin, Elizabeth
    Jaar, Bernard
    Matsushita, Kunihiro
    CIRCULATION, 2019, 139
  • [23] Pulse pressure and prevalence of peripheral arterial disease: The atherosclerosis risk in communities (ARIC) study
    Taylor, HA
    Brown, AC
    Burchfiel, CM
    Jones, DW
    Skelton, TN
    Arnett, DK
    Clemons, TL
    Clark, BL
    Criqui, MH
    CIRCULATION, 2001, 103 (09) : 1361 - 1361
  • [24] The American Heart Association's Life Simple 7 and Risk of Peripheral Arterial Disease: The Atherosclerosis Risk in Communities (ARIC) Study
    Garg, Parveen
    O'Neal, Wesley T.
    Mok, Yejin
    Coresh, Joseph
    Heiss, Gerardo
    Matsushita, Kunihiro
    CIRCULATION, 2017, 136
  • [25] Plasma Urate and Parkinson's Disease in the Atherosclerosis Risk in Communities (ARIC) Study
    Chen, Honglei
    Mosley, Thomas H.
    Alonso, Alvaro
    Huang, Xuemei
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 169 (09) : 1064 - 1069
  • [26] Plasma urate and Parkinson's disease in the atherosclerosis risk on communities (ARIC) study
    Chen, Honglei
    Mosley, Thomas H., Jr.
    Alonso, Alvaro
    Huang, Xuemei
    NEUROLOGY, 2008, 70 (11) : A232 - A232
  • [27] Anemia as a risk factor for cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study
    Sarnak, MJ
    Tighiouart, H
    Manjunath, G
    MacLeod, B
    Griffith, J
    Salem, D
    Levey, AS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (01) : 27 - 33
  • [28] Hemostatic Factors and Long-Term Risk of Peripheral Arterial Disease: The Atherosclerosis Risk in Communities (ARIC) Study
    Wu, Aozhou
    Ballew, Shoshana H.
    Kalbaugh, Corey A.
    Loehr, Laura R.
    Kucharska-Newton, Anna
    Hoogeveen, Ron C.
    Ballantyne, Christie M.
    Heiss, Gerardo
    Folsom, Aaron R.
    Coresh, Josef
    Matsushita, Kunihiro
    CIRCULATION, 2017, 135
  • [29] Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study
    Chambless, LE
    Folsom, AR
    Sharrett, AR
    Sorlie, P
    Couper, D
    Szklo, M
    Nieto, FJ
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (09) : 880 - 890
  • [30] Microvascular Brain Disease and Risk of Stroke: The Atherosclerosis Risk in Communities (ARIC) Study
    Koton, Silvia
    Schneider, Andrea L. C.
    Windham, B. Gwen
    Mosley, Thomas H.
    Gottesman, Rebecca F.
    Coresh, Josef
    ANNALS OF NEUROLOGY, 2016, 80 : S83 - S84